Skip to main content
. 2019 Oct 15;105(1):290–304. doi: 10.1210/clinem/dgz050

Table 1.

Subgroup Comparison at Baseline (diagnosis; T0): Patients With and Without Obstructive Sleep Apnea Syndrome (OSAS)

Baseline (T0) Characteristics Patients With OSAS (N = 20) Patients Without OSAS (N = 7) P Value
Sex, male (%) 11 (55) 1 (14.3) 0.09
Age (years) 49.7 ± 11.7 55.9 ± 17.9 0.42
Weight (kg) 95.3 ± 18.5 73.1 ± 16.5 0.01
BMI (kg/m 2 ) 29.7 ± 3.8 26.1 ± 4.1 0.07
Duration of symptoms (years) 8 (2–20) 6 (5–28) 0.74
Diabetes mellitus (N, %) 5 (25) 0 (0) 0.28
Hypothyroidism (N, %) 2 (10) 0 (0) 1
Hypocortisolism (N, %) 2 (10) 0 (0) 1
Hypogonadism (N, %) 7 (35) 1 (14.3) 0.63
Random GH (µg/L) 9.4 (2.4-32.6) 7.3 (1.8 -127.7) 0.28
IGF-1 (nmol/L) 106 ± 34.3 81.1 ± 31.1 0.1
IGF-1 SDS 7.8 (5.2-23.2) 5.6 (3.5-12.7) 0.08
Current smoker (N, %) 0 (0) 2 (28.6) 0.06
Alcohol consumption: yes (N, %) 15 (75) 3 (42.9) 0.18
Macroadenoma (N, %) 15 (75) 4 (57.1) 0.36
Microadenoma (N, %) 5 (25) 2 (28.6)
GHRH-producing NET (N, %) 0 (0) 1 (14.3 )
AHI (/hour) 19.8 (5.8-64.6) 2.9 (0.5-6.1) <0.001
RDI (/hour) 27.9 (7.9-99.2) 5.2 (1.2-7.1) <0.001
ODI (/hour) 19.8 (0.6-80.5) 4.1 (1.5-7.1) 0.002
LSaO 2  (%) 81.3 ± 6.4 84.8 ± 5.3 0.2
ESS 11.3 (4.8) 12 (3.1) 0.78
OSAS type (N, %)
 Obstructive 20 (100) NA NA
 Central 0 (0)

Values are displayed as mean with (SD) or as median with minimum and maximum, depending on the normality of the distribution. Categorical variables are displayed as numbers (percentage). Abbreviations: AHI, apnea hypopnea index; BMI, body mass index in kg/m2; ESS, Epworth Sleepiness Scale; GH, growth hormone; GHRH, GH-releasing hormone; IGF-1, insulin-like growth factor 1; LSaO2, lowest oxygen saturation; NA, not applicable; ODI, oxygen desaturation index; OSAS, obstructive sleep apnea syndrome; RDI, respiratory disturbance index; SDS, standard deviation score.